BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20429759)

  • 1. Whole-body MRI in follow-up of patients with renal cell carcinoma.
    Platzek I; Zastrow S; Deppe PE; Grimm MO; Wirth M; Laniado M; Stroszczynski C
    Acta Radiol; 2010 Jun; 51(5):581-9. PubMed ID: 20429759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
    Schmidt GP; Baur-Melnyk A; Haug A; Heinemann V; Bauerfeind I; Reiser MF; Schoenberg SO
    Eur J Radiol; 2008 Jan; 65(1):47-58. PubMed ID: 18082989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The staging of renal-cell carcinomas in MRT and CT--a prospective histologically controlled study].
    Hallscheidt P; Stolte E; Roeren T; Pomer S; Drehmer I; Kauffmann GW
    Rofo; 1998 Feb; 168(2):165-70. PubMed ID: 9519049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
    Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
    Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation.
    Hallscheidt PJ; Fink C; Haferkamp A; Bock M; Luburic A; Zuna I; Noeldge G; Kauffmann G
    J Comput Assist Tomogr; 2005; 29(1):64-8. PubMed ID: 15665685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
    Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
    Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
    Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K
    J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MSCT and MRI findings of collecting duct carcinoma.
    Zhu Q; Wu J; Wang Z; Zhu W; Chen W; Wang S
    Clin Radiol; 2013 Oct; 68(10):1002-7. PubMed ID: 23726725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.
    Sohaib SA; Cook G; Allen SD; Hughes M; Eisen T; Gore M
    Br J Radiol; 2009 Aug; 82(980):632-9. PubMed ID: 19221182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
    Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
    Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
    Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
    Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Magnetic resonance tomographic identification and characterization of renal space-occupying lesions using GE-sequences with application of Gd-DTPA].
    Würstlin S; Arlart IP; Guhl L; Nagler-Reus N; Edelman RR
    Rofo; 1993 Jun; 158(6):518-24. PubMed ID: 8507841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
    Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced magnetic resonance imaging assessment of kidney function and renal masses: single slice versus whole organ/tumor.
    Winter KS; Helck AD; Ingrisch M; Staehler M; Stief C; Sommer WH; Braunagel M; Kazmierczak PM; Reiser MF; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2014 Nov; 49(11):720-7. PubMed ID: 24901546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging of small renal masses in real practice: sensitivity and specificity according to subjective radiologic interpretation.
    Kim JH; Sun HY; Hwang J; Hong SS; Cho YJ; Doo SW; Yang WJ; Song YS
    World J Surg Oncol; 2016 Oct; 14(1):260. PubMed ID: 27729042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI.
    Meloni MF; Bertolotto M; Alberzoni C; Lazzaroni S; Filice C; Livraghi T; Ferraioli G
    AJR Am J Roentgenol; 2008 Oct; 191(4):1233-8. PubMed ID: 18806170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary study of whole-body diffusion-weighted imaging in detecting pulmonary metastatic lesions from clear cell renal cell carcinoma: comparison with CT.
    Liu J; Yang X; Li F; Wang X; Jiang X
    Acta Radiol; 2011 Nov; 52(9):954-63. PubMed ID: 21903870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer staging in a single session: whole-body PET/CT mammography.
    Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
    J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI.
    Egbert ND; Caoili EM; Cohan RH; Davenport MS; Francis IR; Kunju LP; Ellis JH
    AJR Am J Roentgenol; 2013 Aug; 201(2):347-55. PubMed ID: 23883215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography and magnetic resonance imaging of adult renal cell carcinoma associated with Xp11.2 translocation.
    Dang TT; Ziv E; Weinstein S; Meng MV; Wang Z; Coakley FV
    J Comput Assist Tomogr; 2012; 36(6):669-74. PubMed ID: 23192203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.